Unique ID issued by UMIN | UMIN000006034 |
---|---|
Receipt number | R000007145 |
Scientific Title | Clinical trial-Efficacy and safety of TAZ/PIPC in elderly respiratory tract infection-NHCAP- |
Date of disclosure of the study information | 2011/07/27 |
Last modified on | 2015/01/26 09:11:07 |
Clinical trial-Efficacy and safety of TAZ/PIPC in elderly respiratory tract infection-NHCAP-
Clinical trial-Efficacy and safety of TAZ/PIPC in elderly respiratory tract infection-NHCAP-
Clinical trial-Efficacy and safety of TAZ/PIPC in elderly respiratory tract infection-NHCAP-
Clinical trial-Efficacy and safety of TAZ/PIPC in elderly respiratory tract infection-NHCAP-
Japan |
elderly respiratory tract infection
Pneumology |
Others
YES
To verify the pharmacological efficacy and safety of TAZ/PIPC(Tazobactam/piperacillin)in elderly over 65 years old respiratory tract infection
Safety,Efficacy
1)Clinical effect of three days later from starting of administration
2)Body temperature,amount of sputum,
property of sputum,WBC,ESR,CRP of three days later from starting of administration
3)Total clinical effect of the analysis objects
4)Bacteriological effect of the analysis objects
5)The incidence of the side effects
6)Pharmacological assessment
Observational
65 | years-old | <= |
Not applicable |
Male and Female
1 elderly people over 65 years old
2 the case fulfilling any of under the points
-examined in long-term health facilities for recuperation, the treatment
-discharged within 180 days
-elderly or handicapped need care
-who have received endovascular treatment continued at the hospital (dialysis, antibiotics, anticancer, immunosuppressant therapy, etc.)
3 the case fulfilling all under points two days before from starting of administration
-a body temperature higher than 37 degrees C
-CRP higher than 1.0mg per dl
-evidence of pneumonia in the chest radiography or chest CT
1 under severe heart damage
under severe liver damage
under severe kidney damage
2 who is strongly suspected of atypical pneumonia
3 who must be used with non-macrolide antibiotics
4 beta lactam agent allergy
5 who evaluated as inappropriate by doctor in attendance
20
1st name | |
Middle name | |
Last name | FumiKARINO |
Shimane University Faculty of Medicine
Oncology and Respiratory Medicine
89-1 Enya-cho Izumo Shimane 693-8501 JAPAN
0853-20-2580
fumi1224@med.shimane-u.ac.jp
1st name | |
Middle name | |
Last name | FumiKARINO |
Shimane University Faculty of Medicine
Oncology and Respiratory Medicine
89-1 Enya-cho Izumo Shimane 693-8501 JAPAN
0853-20-2580
fumi1224@med.shimane-u.ac.jp
Shimane University Faculty of Medicine
Shimane University Faculty of Medicine
Self funding
NO
2011 | Year | 07 | Month | 27 | Day |
Unpublished
Open public recruiting
2010 | Year | 12 | Month | 27 | Day |
2010 | Year | 12 | Month | 01 | Day |
To verify the pharmacological efficacy and safety of TAZ/PIPC(Tazobactam/piperacillin)in elderly over 65 years old respiratory tract infection
observation point
1)Clinical effect of three days later from starting of administration
2)Body temperature,amount of sputum,
property of sputum,WBC,ESR,CRP of three days later from starting of administration
3)Total clinical effect of the analysis object
4)Bacteriological effect of the analysis object
5)The incidence of the side effect
6)Pharmacological assessment
2011 | Year | 07 | Month | 25 | Day |
2015 | Year | 01 | Month | 26 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007145
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |